Market revenue in 2023 | USD 158.9 million |
Market revenue in 2030 | USD 281.1 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.36% in 2023. Horizon Databook has segmented the Japan clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has been one of the major attractions for biopharmaceuticals and global CROs due to advancements in technology, policy reforms, faster recruitment of patients, and presence of a developed R&D infrastructure.
These factors are expected to drive clinical research, which is expected to further increase the demand for efficient supply chain, thereby propelling growth of clinical trial supply and logistics market in this country.
The Pharmaceutical and Medical Device Agency, the regulatory body in Japan, has streamlined review and approval process of drugs, which is anticipated to attract biopharmaceutical companies to conduct trials and promote entry of clinical trial supplies players.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into Japan clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account